The relationships between pre-meal VAS scores and EI were examined using correlation, linear models (including subject characteristics) and a cross-validation procedure.
We analyzed the AV accumulation data on mean counts of AVs per cell using mixed models including subject id as a random effect and cohort (dose-finding vs. melanoma extension), dose, and time (baseline vs. after HCQ vs. after HCQ + TMZ) as fixed factors.
Our models included subjects (subject ID) and scenes (scenes ID) as random effects to capture variance attributed to the randomness of subject and item sampling.
ANCOVA models included subjects who had available data for all covariates, in addition to the baseline and follow-up scores of the respective outcome scale.
Covariate analysis was part of the initial incentive behind the development of NLME: to find correlations between subject-specific characteristics, such as age and weight, with the properties in the model, including subject-specific responses to drug treatments [ 34].
We attributed the differences among our study and others to different experiment model including study subjects, stimulus, and especially the analysis timing.
This model included subject-specific intercepts A ci, representing subject-specific adjusted log prevalence rates, to be used in the second-level models.
This is of particular interest since Fyn has been implicated in AD pathogenesis across various models, including human subjects [ 23].
Based on bivariate Cox proportional hazards models including all subjects, the presence of involved vessels is associated with an increase in risk of death (risk ratio = 2.9, 3.0 and 4.6 for 1, 2 and 3 vessels, respectively; P = 0.06).
Since discovery that L-arginine is the only substrate for endothelial cells to produce the vasoprotective molecule NO via eNOS [ 3], L-arginine supplementation is widely investigated for decades to boost NO production in different models including human subjects in vivo.
